Aptamer Group PLC

0.29pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:APTAHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 5Y CAGR (71.87%)
Div yield —
ROE (52.31%)
Biotechnology
Beta (5Y) 0.85
PE TTM —
TSR TTM (65.45%)
Mkt cap £10.02M
ROIC (44.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
0.327p
12.76%
(80.57%)
Hold 8|10|10|6|8
2Q26
3Q26
4Q26
1Q27
Earnings per share£
—
—
0.01
0.01
13.81%
12.68%
23.83%
39.10%
Revenue£M
0.534
0.534
0.530
0.543
6.67%
8.11%
3.64%
7.17%
Peers (US$13.13M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.296
—
—
EBIT/Intx
2.571
1.669
1.811
Own earn%
(67.64)
35.86
24.67
Sh yield%
35.79
24.98
26.55
Owners
Insiders/Inst%
14.43
59.85
Short interest%
3.64
SBC / revenue%
0.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
18–24
$1 testx
0.0
Incr. ROIC%
8